Inventor · disambiguated record
Kate Dora Games
Also filed as: GAMES KATE D · GAMES KATE DORA
9 granted patents·11 pending applications·265 citations·filing 1998–2024
91Inventor score
Files withSCHENK DALE B7PROTHENA BIOSCIENCES LTD5ELAN PHARM INC4SCHROETER SALLY2JANSSEN ALZHEIMER IMMUNOTHERAP1
Top patents by PatentIndex Score
20 records- 0194US8092801B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Jan 10, 2012·44 cites·15 claims
- 0294US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 0393US8147833B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Apr 3, 2012·18 cites·4 claims
- 0491US8506959B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2005·Granted Aug 13, 2013·13 cites·15 claims
- 0591US8003097B2Treatment of cerebral amyloid angiopathyJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2008·Granted Aug 23, 2011·41 cites·13 claims
- 0687US6664442B2Selecting compounds to reduce inflammation associated with Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Dec 16, 2003·29 cites·43 claims
- 0786US6717031B2Method for selecting a transgenic mouse model of alzheimer's diseaseFiled 1998·Granted Apr 6, 2004·50 cites·56 claims
- 0885US7186881B2Testing compounds for effects on synaptophysin in transgenic mice expressing an Alzheimer's disease FAD DNA sequenceELAN PHARM INC·Filed 2003·Granted Mar 6, 2007·23 cites·10 claims
- 0983US9034337B2Treatment and delay of outset of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted May 19, 2015·7 cites·15 claims
- 1070US2021032318A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 1168US2024254211A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1266US2019300598A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 1362US2017349651A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2017·Application pending·0 cites
- 1459US2012201842A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2012·Application pending·0 cites
- 1556US2016060331A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2015·Application pending·0 cites
- 1655US2012142902A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 1750US2010031377A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2005·Application pending·0 cites
- 1847US2016184416A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2015·Application pending·0 cites
- 1943US2012282248A1Prevention and treatment of cerebral amyloid angiopathySCHROETER SALLY·Filed 2011·Application pending·0 cites
- 2041US2008292625A1Prevention and treatment of cerebral amyloid angiopathySCHROETER SALLY·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →